Chronic Condition Management

Improved efficiency in allergy testing and management can close a critical gap in care for patients struggling to control their symptoms.

Manage patients with atrial fibrillation to boost payments under MIPS.

Focus on three things for a successful patient interview during a visit: what the doctor thinks the problem is, what the patient thinks the problem is, and each of their goals.

Three simple ways healthcare teams can leverage surveys to make pain management more proactive.

With the right tools, partnerships, and commitment to collaboration, embracing “data utilization” will feel far less overwhelming, and providers will be positioned to enact tangible, positive changes.

Countless physician groups are grappling with how best to introduce and leverage genomics in their practices.

Study suggests all adults age 18 and older should be screened for HCV. 

Shorter treatment could significantly reduce costs of therapy.

Change is difficult for healthcare professionals but especially difficult in a for-profit healthcare system setting-especially those systems caring for high-risk populations.

Improve outcomes, boost payment

It is crucial for physicians to know how to legally handle what is still considered an illegal substance in some jurisdictions

Effective direct-acting antivirals are available for teens.

Strong evidence supports removal of restrictions to direct-acting antiviral therapy based on recent drug use.

Shared diabetes services may be essential to successfully treating patients with this disease without overburdening physicians.

Two studies show these kidneys could be valuable resource for patients in need

New approaches are needed for physicians to engage young people who inject drugs

An urgent call to action to treat combined epidemics

Glucose tolerance is an independent predictor of overall mortality and hepatic decompensation in patients with HCV cirrhosis.

Physicians share the benefits of having nurse practitioners available at their practices to aid both patients and fellow healthcare clinicians.

Ledipasvir/sofosbuvir is safe and effective for hepatitis C virus patients who fail on simeprevir/ sofosbuvir.

Real-world study shows efficacy of sofosbuvir/velpatasvir for 12 weeks

Sofosbuvir-velpatasvir-voxilaprevir provides salvage therapy for NS5A failures

Despite the availability of new, highly successful direct-acting antiviral (DAA) regimens, more than one third of chronic hepatitis C (HCV) patients are denied access to treatment by their insurance provider, according to a new study.

For the White House to meet its goals on stopping the nation’s opioid crisis, there are some practical steps to put in place first.